Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups.

Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, Rudat V, Schild SE.

Radiat Oncol. 2018 Feb 8;13(1):21. doi: 10.1186/s13014-018-0968-3.

2.

Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial.

Rades D, Conde-Moreno AJ, Cacicedo J, Šegedin B, Stanic K, Metz M, Rudat V, Schild SE.

Anticancer Res. 2018 Feb;38(2):1009-1015.

PMID:
29374734
3.

Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression.

Rades D, Veninga T, Conde-Moreno AJ, Cacicedo J, Metz M, Šegedin B, Norkus D, Rudat V, Schild SE.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):137-144. doi: 10.1016/j.prro.2016.07.005. Epub 2016 Jul 25.

PMID:
28274397
4.

Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy : Results of a single, institutional, retrospective study.

Rudat V, Nour A, Hammoud M, Abou Ghaida S.

Strahlenther Onkol. 2017 May;193(5):375-384. doi: 10.1007/s00066-017-1115-z. Epub 2017 Feb 23.

5.

Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression.

Rades D, Janssen S, Conde-Moreno AJ, Cacicedo J, Metz M, Veninga T, Segedin B, Rudat V, Schild SE.

J Med Imaging Radiat Oncol. 2017 Jun;61(3):388-393. doi: 10.1111/1754-9485.12553. Epub 2016 Nov 2.

PMID:
27804231
6.

Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma.

Rades D, Conde-Moreno AJ, Cacicedo J, Segedin B, Rudat V, Schild SE.

Radiol Oncol. 2016 Jul 19;50(3):337-40. doi: 10.1515/raon-2016-0029. eCollection 2016 Sep 1.

7.

Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy.

Rudat V, Nour A, Ghaida SA, Alaradi A.

Radiat Oncol. 2016 Jul 30;11:100. doi: 10.1186/s13014-016-0674-y.

8.

Radiation Therapy Alone Provides Excellent Outcomes for Spinal Cord Compression from Vertebral Lymphoma.

Rades D, Conde-Moreno AJ, Cacicedo J, Šegedin B, Rudat V, Schild SE.

Anticancer Res. 2016 Jun;36(6):3081-3.

PMID:
27272831
9.

A scoring system for predicting the survival prognosis of patients receiving stereotactic body radiation therapy (SBRT) for 1-3 lung metastases.

Janssen S, Kaesmann L, Rudat V, Rades D.

Lung. 2016 Aug;194(4):631-5. doi: 10.1007/s00408-016-9906-z. Epub 2016 Jun 4.

PMID:
27263126
10.

Stereotactic Body Radiotherapy Provides Excellent Long-Term Local Control of Very Few Lung Metastases.

Janssen S, Käsmann L, Rudat V, Rades D.

In Vivo. 2016 Mar-Apr;30(2):155-7.

PMID:
26912828
11.

Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC).

Janssen S, Käsmann L, Rudat V, Rades D.

Anticancer Res. 2016 Feb;36(2):825-8.

PMID:
26851047
12.

Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC).

Janssen S, Kaesmann L, Rudat V, Rades D.

Lung. 2016 Apr;194(2):291-4. doi: 10.1007/s00408-016-9849-4. Epub 2016 Feb 3.

PMID:
26842723
13.

Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).

Rades D, Šegedin B, Conde-Moreno AJ, Garcia R, Perpar A, Metz M, Badakhshi H, Schreiber A, Nitsche M, Hipp P, Schulze W, Adamietz IA, Norkus D, Rudat V, Cacicedo J, Schild SE.

J Clin Oncol. 2016 Feb 20;34(6):597-602. doi: 10.1200/JCO.2015.64.0862. Epub 2016 Jan 4.

PMID:
26729431
14.

Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.

Rudat V, Nour A, Hammoud M, Alaradi A, Mohammed A.

Strahlenther Onkol. 2016 Feb;192(2):109-17. doi: 10.1007/s00066-015-0919-y. Epub 2015 Nov 6.

15.

Predicting Survival After Irradiation for Brain Metastases from Head and Neck Cancer.

Rades D, Dziggel L, Hakim SG, Rudat V, Janssen S, Trang NT, Khoa MT, Bartscht T.

In Vivo. 2015 Sep-Oct;29(5):525-8.

PMID:
26359409
16.

Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.

Rades D, Huttenlocher S, Šegedin B, Perpar A, Conde AJ, Garcia R, Veninga T, Stalpers LJ, Cacicedo J, Rudat V, Schild SE.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):368-72. doi: 10.1016/j.ijrobp.2015.05.042. Epub 2015 Jun 3.

PMID:
26232852
17.

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.

Rades D, Huttenlocher S, Veninga T, Bajrovic A, Bremer M, Rudat V, Schild SE.

Radiat Oncol. 2015 Apr 15;10:90. doi: 10.1186/s13014-015-0403-y.

18.

MRI and Ultrasonography for assessing multifocal disease and tumor size in breast cancer: Comparison with histopathological results.

Rudat V, Nour A, Almuraikhi N, Ghoniemy I, Brune-Erber I, Almasri N, El-Maghraby T.

Gulf J Oncolog. 2015 Jan;1(17):65-72.

PMID:
25682455
19.

Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses.

Rades D, Huttenlocher S, Rudat V, Hornung D, Blanck O, Phuong PC, Khoa MT, Schild SE, Fischer D.

Anticancer Res. 2015 Jan;35(1):333-6.

PMID:
25550568
20.

Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients.

Huttenlocher S, Sehmisch L, Rudat V, Rades D.

J Dermatol. 2014 Dec;41(12):1082-6. doi: 10.1111/1346-8138.12659. Epub 2014 Oct 20.

PMID:
25327333
21.

A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression.

Rades D, Evers JN, Rudat V, Bajrovic A, Karstens JH, Schild SE.

BMC Cancer. 2014 Aug 14;14:589. doi: 10.1186/1471-2407-14-589.

22.

In vivo surface dose measurement using GafChromic film dosimetry in breast cancer radiotherapy: comparison of 7-field IMRT, tangential IMRT and tangential 3D-CRT.

Rudat V, Nour A, Alaradi AA, Mohamed A, Altuwaijri S.

Radiat Oncol. 2014 Jul 15;9:156. doi: 10.1186/1748-717X-9-156.

23.

Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis.

Rudat V, El-Sweilmeen H, Brune-Erber I, Nour AA, Almasri N, Altuwaijri S, Fadel E.

BMC Cancer. 2014 Apr 24;14:289. doi: 10.1186/1471-2407-14-289.

24.

Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity.

Nour AA, Alaradi A, Mohamed A, Altuwaijri S, Rudat V.

Radiat Oncol. 2013 Sep 5;8:207. doi: 10.1186/1748-717X-8-207.

25.

Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer.

Rades D, Douglas S, Huttenlocher S, Veninga T, Bajrovic A, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Dec;188(12):1114-8. doi: 10.1007/s00066-012-0141-0. Epub 2012 Nov 1.

PMID:
23111468
26.

Impact of zoledronic acid on control of metastatic spinal cord compression.

Rades D, Hakim SG, Bajrovic A, Karstens JH, Veninga T, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Oct;188(10):910-6. Epub 2012 Aug 19.

PMID:
22903395
27.

Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.

Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D.

BMC Cancer. 2012 Jun 21;12:261. doi: 10.1186/1471-2407-12-261.

28.

Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia.

Rudat V, El-Sweilmeen H, Fadel E, Brune-Erber I, Ahmad Nour A, Bushnag Z, Masri N, Altuwaijri S.

J Oncol. 2012;2012:370385. doi: 10.1155/2012/370385. Epub 2012 Apr 1.

29.

A survival score for patients with metastatic spinal cord compression from prostate cancer.

Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJ, Hoskin PJ, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Sep;188(9):802-6. Epub 2012 Apr 25.

PMID:
22526228
30.

Prognostic factors for local control and survival in patients with spinal cord compression from myeloma.

Rades D, Douglas S, Veninga T, Poortmans P, Bajrovic A, Hoskin PJ, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Jul;188(7):628-31. doi: 10.1007/s00066-012-0077-4. Epub 2012 Mar 14.

PMID:
22410834
31.

Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.

Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJ, Hoskin PJ, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Jun;188(6):472-6. doi: 10.1007/s00066-012-0086-3. Epub 2012 Feb 25.

PMID:
22361746
32.

Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.

Rades D, Douglas S, Veninga T, Stalpers LJ, Bajrovic A, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Apr;188(4):340-5. doi: 10.1007/s00066-011-0061-4. Epub 2012 Feb 23.

PMID:
22354333
33.

Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?

Rades D, Huttenlocher S, Evers JN, Bajrovic A, Karstens JH, Rudat V, Schild SE.

Strahlenther Onkol. 2012 May;188(5):424-30. doi: 10.1007/s00066-011-0058-z. Epub 2012 Feb 16.

PMID:
22349635
34.

Definitive Radiotherapy versus Postoperative Radiotherapy of Patients with Oro- and Hypopharyngeal Cancer: Impact of Prognostic Factors.

Rudat V, Ahmet-Osman S, Schramm O, Dietz A.

J Oncol. 2012;2012:391917. doi: 10.1155/2012/391917. Epub 2012 Jan 18.

35.

Epidemiology of breast cancer patients at a tertiary care center in the Eastern Province of Saudi Arabia.

Rudat V, Brune-Erbe I, Noureldin A, Bushnag Z, Almuraikhi N, Altuwaijri S.

Gulf J Oncolog. 2012 Jan;(11):45-9.

PMID:
22227545
36.

Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.

Rades D, Panzner A, Rudat V, Karstens JH, Schild SE.

Strahlenther Onkol. 2011 Nov;187(11):729-35. doi: 10.1007/s00066-011-2266-y. Epub 2011 Oct 28.

PMID:
22037654
37.

Impact of the frequency of online verifications on the patient set-up accuracy and set-up margins.

Rudat V, Hammoud M, Pillay Y, Alaradi AA, Mohamed A, Altuwaijri S.

Radiat Oncol. 2011 Aug 24;6:101. doi: 10.1186/1748-717X-6-101.

38.

Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.

Rades D, Meyners T, Kazic N, Bajrovic A, Rudat V, Schild SE.

Strahlenther Onkol. 2011 Sep;187(9):541-7. doi: 10.1007/s00066-011-2262-2. Epub 2011 Aug 16.

PMID:
21858415
39.

Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison.

Rudat V, Alaradi AA, Mohamed A, Ai-Yahya K, Altuwaijri S.

Radiat Oncol. 2011 Mar 21;6:26. doi: 10.1186/1748-717X-6-26.

40.

Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.

Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Adamietz IA, Kazic N, Rudat V, Schild SE.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e861-8. doi: 10.1016/j.ijrobp.2010.11.056. Epub 2011 Jan 27.

PMID:
21277114
41.

Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression.

Rades D, Huttenlocher S, Dunst J, Bajrovic A, Karstens JH, Rudat V, Schild SE.

J Clin Oncol. 2010 Aug 1;28(22):3597-604. doi: 10.1200/JCO.2010.28.5635. Epub 2010 Jul 6.

PMID:
20606090
42.

Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression.

Rades D, Douglas S, Huttenlocher S, Rudat V, Veninga T, Stalpers LJ, Basic H, Karstens JH, Hoskin PJ, Adamietz IA, Schild SE.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1503-6. doi: 10.1016/j.ijrobp.2010.01.024. Epub 2010 Jun 3.

PMID:
20605351
43.

Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.

Rades D, Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH, Adamietz IA, Wildfang I, Rudat V, Schild SE, Dunst J.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1492-7. doi: 10.1016/j.ijrobp.2010.04.026. Epub 2010 Jun 25.

PMID:
20579816
44.

Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.

Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE.

Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):524-30. doi: 10.1016/j.ijrobp.2009.10.073. Epub 2010 May 6.

PMID:
20452136
45.

Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.

Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH, Adamietz IA, Rudat V, Schild SE, Dunst J, Rades D.

Strahlenther Onkol. 2010 Apr;186(4):218-23. doi: 10.1007/s00066-010-2110-9. Epub 2010 Mar 26.

PMID:
20354660
46.

Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.

Dunst J, Debus J, Rudat V, Wulf J, Budach W, Hoelscher T, Reese T, Mose S, Roedel C, Zuehlke H, Hinke A.

Strahlenther Onkol. 2008 Sep;184(9):450-6. doi: 10.1007/s00066-008-1751-4. Epub 2008 Sep 19.

PMID:
19016023
47.

Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).

Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R, Pfreundner L, Schröder U, Eckel H, Hess M, Schröder M, Schneider P, Jens B, Zenner HP, Werner JA, Engenhardt-Cabillic R, Vanselow B, Plinkert P, Niewald M, Kuhnt T, Budach W, Flentje M.

Eur Arch Otorhinolaryngol. 2009 Aug;266(8):1291-300. doi: 10.1007/s00405-008-0846-y. Epub 2008 Oct 30.

PMID:
18972123
48.

The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.

Rudat V, Münter M, Rades D, Grötz KA, Bajrovic A, Haberkorn U, Brenner W, Debus J.

Radiother Oncol. 2008 Oct;89(1):71-80. doi: 10.1016/j.radonc.2008.07.016. Epub 2008 Aug 15.

PMID:
18707782
49.

Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.

Rades D, Rudat V, Veninga T, Stalpers LJ, Hoskin PJ, Schild SE.

Cancer. 2008 Sep 1;113(5):1090-6. doi: 10.1002/cncr.23702.

50.

Long-term results of a prospective multicenter phase II study to preserve the larynx function using concomitant boost radiochemotherapy with Carboplatin.

Rudat V, Eckel H, Volling P, Schröder M, Staar S, Wallner F, Wannenmacher M, Dietz A.

Radiother Oncol. 2008 Oct;89(1):33-7. doi: 10.1016/j.radonc.2008.06.005. Epub 2008 Jul 11.

PMID:
18621428

Supplemental Content

Support Center